Clinical Trials Directory

Trials / Completed

CompletedNCT05215626

PMCF Study on the Safety, Performance and Clinical Benefits Data of the Zimmer® Reconstruction System

Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Zimmer® Reconstruction System (Implant and Instrumentation) - A Retrospective Consecutive Series Study

Status
Completed
Phase
Study type
Observational
Enrollment
78 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is a monocentric, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to confirm safety, performance and clinical benefits of the Reconstruction System (implants and instrumentation) when used for temporary internal fixation and stabilization of fractures during the normal healing process. The primary objective is the assessment of performance by analyzing fracture healing. The secondary objectives are the assessment of safety by recording and analyzing the incidence and frequency of complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified. Subjects' outcomes will also be assessed.

Detailed description

The Reconstruction System is especially used to stabilize pelvic ring and acetabulum fractures. One site will be involved in this study. The aim is to include a maximum of 83 consecutive series cases who received the Zimmer Reconstruction System at the Azienda Ospedaliero Universitaria Senese (Siena, Italy) between 2010 and 2018. All potential study subjects will be required to participate to the Informed Consent process. Baseline data from the preop, intraop, immediate post-op and last consultation visit will be available in medical notes and collected retrospectively. In addition, any complications since the last consultation visit at the clinic and information about the treatment of the complications will also be collected retrospectively.

Conditions

Timeline

Start date
2022-08-01
Primary completion
2024-06-16
Completion
2024-12-12
First posted
2022-01-31
Last updated
2026-03-10
Results posted
2026-03-10

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05215626. Inclusion in this directory is not an endorsement.